TIP 63: Medications for Opioid Use Disorder - Executive Summary

This poster lists five simple ways to reduce the risks of taking methadone for pain relief or medication-assisted treatment of opioid use disorders. It also offers suggested resources for additional information. The poster comes folded and is 11 inches x 15 inches.

This poster lists five simple ways to reduce the risks of taking methadone for pain relief or medication-assisted treatment of opioid use disorders. It also offers suggested resources for additional information. The poster comes folded and is 11 inches x 15 inches.

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

This guide explains how to use extended-release injectable naltrexone as part of medication-assisted treatment (MAT) for opioid use disorder. It covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.